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In this report, we describe the cloning, over-expression, efficient solubilization, purification and evaluation of 
bioactivity of camel growth hormone (cGH). The total cellular RNA was extracted from pituitary glands 
of freshly slaughtered animals and cDNA of cGH was synthesized by a pair of sequence specific 
primers with a product of 576 base pairs (bps). Amplicons was cloned into T/A cloning vector and 
positive clones were subjected to sequencing. After sequencing, cDNA was cloned in the prokaryotic 
expression vector system pET23b
+
. Conditions for cGH expression were optimized by varying the 
concentration of isopropyl-L-thio-β D-galactopyronoside (IPTG) and induction time. It was observed 
that 100 µM concentration of IPTG and 3 h post-induction produced the highest amount of cGH. 
Expressed GH was sequestered as inclusion bodies (IBs), and was therefore, solubilized using 
denaturant (urea) and detergents (SDS, CTAB, Tritin X-100, Tween-20). The best solubilization was 
obtained with 8.5 mM SDS in 100 mM Tris buffer at pH 8.5. The solubilized cGH was purified by gel 
filtration chromatography using Sephadex G-50 column. The purified protein was refolded by dialysis, 
analyzed on 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and 
confirmed by Western blot. Further biological activity of purified product was confirmed by efficient 
growth of rat Nb2 lymphoma cells.  This study  provided the method  for the efficient  solubilization of 
cGH (r-cGH) with comparable bioactivity with commercially available bovine growth hormone (bGH) and 
could be further used for solubilization of other proteins expressed in prokaryotic system. 
 






Among several other animals, camel (Camelus 
dromederius) is unique in its physiology and services to 
humanity. It provides milk, meat and is also used for 
transportation in the Middle East and several other parts 
of the world. The animal has ability to thrive in harsh 
environment of tropical and drought prone regions and is 
capable of fulfilling milk needs of these regions. It is also 
a source of earning for many low to middle income 
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been shown that camel milk has some unique qualities 
when compared with milk from other mammals (Qureshi, 
1986). Camel milk is superior in its protein, minerals and 
vitamins contents and of importance, it has higher 
stability when compared with other mammalian’s milk 
(Yaqoob and Nawaz, 2007) which is one of the desirable 
characteristics for the camel rearing regions. Camel milk 
has also been reported to exhibit medicinal values 
against a number of diseases like dropsy, jaundice, 
diabetes and conditions affecting the lung and spleen 
(Knoess et al., 1986; Mal et al., 2001; Agrawal et al., 
2003; Guakhar and Bernard, 2004). Thus, camel has 






Lactating animals growth hormones (GH) have been 
exploited through biotechnology to increase milk and 
meat yield and molecular information regarding animals’ 
GH are crucial for further improving this technology. The 
GH in addition to its direct role in normal growth and 
development also regulates several complex physio-
logical processes like metabolism, reproduction and cell 
proliferation (Kostyo and Isaksson, 1977; Hull and 
Harvey, 2001). Due to different biological roles and 
commercial applications especially in livestock, several 
mammalian GHs have been cloned and expressed in 
various expression systems (Yamano et al., 1988; Anathy 
et al., 2001; Mukhopadhyay and Sahni, 2002). As far as 
cGH is concerned, it has been previously purified and 
partially characterized using pituitary extract of the camel. 
In this study, it was found that there is only one form of 
cGH with no glycosylation (Martinat et al. (1990). Maniou 
et al. (2004) cloned and sequenced the cGH and 
reported the molecular evolution of pituitary GH in 
cetartiodactyla.  
It is reported that over expression of GH in prokaryotic 
system results in formation of insoluble aggregates, that 
is, IBs (Ouyang et al., 2003). In order to recover the 
bioactive protein from IBs, four steps are required: cell 
lysis and isolation, solubilization, refolding and purifi-
cation (Vallejo and Rinas, 2004). Solubilization and 
refolding are very critical steps for obtaining high yield of 
bioactive protein. Therefore, a wide range of buffers with 
and without denaturants/detergents have been used for 
solubilization of recombinant protein expressed as IBs 
(Patra et al., 2000). The solubilized proteins were then 
purified by gel filtration (Ayson et al., 2000), ion exchange 
(Funkenstein, 2005) and affinity chromatography (Khalid 
et al., 2008).  
We report here, the results of using SDS as an 
alternative to urea and guanidine HCl for solubilization 
and recovery of r-cGH produced as inclusion bodies in 
prokaryotic system with comparable bioactivity with 
commercially available bGH. 
 
 
MATERIALS AND METHODS 
 
Construction of cGH expression plasmid  
 
Pituitary of camel was collected from freshly slaughtered animal 
and was carried under freeze conditions to the laboratory and 
stored at -70°C before use. RNA was isolated from pituitary by 
using the method described by Chomezynski and Sacci (1987) and 
RNA was stored at -20°C till use. A pair of sequence specific 
primers (Forward 5` CATATGTTCCCAGCCATGCCTCTGTCC3` 
and Reverse 5`GCAACTAGAAGG CACAGCTG 3`) was designed 
based on known cGH sequence (AJ575419) with a restriction site 
for NdeI at the 5’end of forward primer. Bacterial expression system 
was used to express cGH cDNA and hence 5’ primer was designed 
in a way not to include signal peptide sequence. Complementary 
DNA (cDNA) was synthesized by using RevrtAid TM First Strand 
Synthesis Kit (Fermentas, EU) along with three different primers; 
random hexamer, oligo dT and sequence specific. A typical  
polymerase          chain       reaction       (PCR)       was      run     for  




amplification of cGH gene. The thermal profile for amplification of 
cGH cDNA was, pre PCR denaturation at 94°C followed by 33 
cycles of denaturation at 94°C for 30 s, annealing at 58°C for 45 s 
and extension at 72°C for 90 s with final extension at 72°C for 20 
min. 
Putative amplified product was first ligated in a T/A cloning vector 
followed by its transformation into E. coli strain DH5α by the method 
provided with Ins T/A cloneTM PCR product cloning kit (Fermentas, 
EU). The cloning was confirmed with restriction digestion of T/A 
vector with NdeI and SalI. The positive clones were selected and 
sequenced on Beckman Coulter CEQ TM system by using M13 and 
sequence specific primers along with provided protocol. DNA 
sequence of three different clones were aligned by using EBI 
Clustal W. Open reading frame (ORF) was translated into mature 
peptide and homology of cGH mature peptide was compared with 
other mammals by using Justbio Translater and EBI Clustal W, 
respectively.  
Recombinant T/A clone were digested with NdeI and HindIII to 
isolate cGH cDNA. The digested product was run on 1% agarose 
gel and purified with Perfectprep® Gel Cleanup Kit (Eppendorf, 
Germany). The purified product was then directionally sub cloned 
into NdeI and HindIII site of pET23b+ vector which was further 
transformed into BL21(DE3) cells. The sub cloning of CGH cDNA 
was confirmed by digestion with NdeI and HindIII and confirmed 
clones were stored at -70°C. 
 
 
Over expression of cGH 
 
BL21 (DE23) cells harboring pET23b+ vector were streaked on 
Lauria Bertani (LB) agar containing 50 µg/ml ampicillin and allowed 
to grow over night at 37°C. A single colony from LB plate was 
inoculated into 3 ml of LB broth containing 50 µg/ml ampicillin and 
grown overnight at 37°C with shaking incubator at 250 rpm. About 1 
ml of the earlier mentioned culture was added into 100 ml of fresh 
LB broth containing ampicillin and further grown at 37°C. Once an 
OD 600 nm was ~ 0.5, representing the logarithmic phase, different 
concentrations of isopropyl beta-D-1-thiogalactopyranoside (IPTG) 
was added to test optimal over-expression. Then, inoculum was 
grown for various time intervals at 37°C under shaking at 250 rpm. 
The uninduced culture was also grown along with induced culture in 
each experiment. The cells were harvested by centrifugation and 
the pellet was resuspended in 1 ml of cell lysis buffer containing 10 
mM phosphate buffer saline at pH 7.4 and disrupted by sonicating 
discontinuously for 2 min to check the cellular localization of 
expressed protein (Wang et al., 2005).  
 
 
Solubilization of cGH from inclusion bodies 
 
After cell disruption, the suspension was centrifuged at 10000 g for 
20 min at 4°C. The pellet containing insoluble r-cGH IBs was 
washed three times with 1 ml of 50 mM Tris-HCl at pH 8 containing 
10 mM EDTA, 100 mM NaCl and Triton X-100. Finally, IBs were 
washed with two times 1 ml distilled water to remove contaminating 
salt and detergent. Purified IBs containing r-cGH was then 
resuspended in 1 ml of 100 mM Tris buffer (pH 8.0 or 12.5), in the 
presence of 0, 2, 4, 6 and 8 M urea, and 100 mM Tris buffer at pH 
8.0 with 8.5 mM sodium dodecyl sulphate (SDS), 6 mM 
cetyltrimethyl ammonium bromide (CTAB), 0.5 mM Triton X-100, 
and 0.06 mM Tween-20, separately. The suspensions were 
solubilized for 4 h with stirring at room temperature. The solubilized 
IBs were centrifuged at 12000 g for 30 min. The supernatants and 
pellets obtained after solubilization using different denaturant and 
detergents were loaded on 12% SDS-PAGE to check solubilization. 
The supernatant showing maximum solubilization of r-cGH IBs were 
used for further purification. 




Purification of r-cGH 
 
After optimizing over expression and solubilization, the IBs from 1 L 
of culture were solubilized in 10 ml of 0.1 M Tris buffer, pH 8.0 
containing 8.5 mM SDS. The solubilized IB was concentrated by 
using Eppendorf concentrator 5301 (USA) and then quantified with 
BCA assay (Smith et al., 1985). Finally, 1.5 ml of solubilized protein 
having 8 mg/ml protein was applied on gel filtration column 
equilibrated and eluted with the same buffer in which IBs 
solubilization was done. The 2 ml fractions were collected at the 
rate of 0.5 ml/min and the absorbance of individual fractions were 
measured at 280 nm. The fractions having proteins were pooled, 
concentrated and loaded onto Sephadex G-100 column (1.5 x 75 
cm) for further purification. The fractions which showed a single r-
cGH protein band on SDS-PAGE were pooled together, dialyzed 
against 20 mM Tris buffer, pH 8 and lyophilized.  
 
 
SDS–PAGE and Western blotting 
 
The amount of protein expressed, and recovered from IBs and 
during the purification steps were analyzed by 12% SDS-PAGE 
(Laemmli, 1970) and r-cGH was confirmed by immunoblot analysis. 
The protein resolved on 12% SDS PAGE was electrophoretically 
transferred to a nitrocellulose membrane at 90 V for 1 h. After 
blocking with BSA, the nitrocellulose membrane was processed 
using rabbit monoclonal antibody raised against GH and goat anti 
rabbit antibody conjugated to alkaline phosphatase. The antigen-
antibody complexes were detected by developing with 5-bromo-4-
chloro-3-indolyl phosphate and nitroblue tetrazolium as substrate. 
 
 
Biological activity of r-cGH 
 
Nb2 cells obtained from the School of Biological Sciences, Punjab 
University, Lahore, Pakistan were used for the study. Prior to assay, 
cell growth was arrested by incubating cells in RPMI 1640 medium 
with L- glutamine and without sodium bicarbonate supplemented 
with 1% fetal bovine serum, 10% horse serum and 1% penicillin 
streptomycin solution (PSS) for 24 h. Different concentrations (0, 
10, 20, 30, 40 and 50 ng/ml) of bovine serum albumin, 
commercially available Boostin (bovine somatotropin; bST, Life 
Sciences, Korea) and purified r-cGH were added separately into 
culture medium and then incubated for 72 h in the humidified CO2 
incubator at 37°C. All proteins and controls were done in triplicate 
and three separate experiments were carried out. The cells 




RESULTS AND DISCUSSION 
 
Construction of cGH expression plasmid  
 
The amplification of cGH CDS was done with sequence 
specific primers and a single band of 576 bp was 
obtained as expected. The result is consistent with the 
results of Khalid et al. (2007) in which 576 bp product 
was obtained from buffalo growth hormone cDNA with 
sequence specific primers. The amplicons were ligated in 
T/A cloning vector pTZ57R/T and transformed into DH5α 
for further propagation. Cloning was confirmed by 





from transformed cells with NdeI and HindIII. A fragment 
of 576 bp was reproduced upon digestion which 
confirmed the cloning of cGH CDS.  
Positive clones were used for sequencing and sequen-
ced obtained showed 100% homology with previously 
reported GH sequence of Arabian camel (AJ575419). 
Similarly, multiple sequence alignments of mature cGH 
showed high homology with other mammalian GHs like 
Bubalus bubalis (91%), Bos indicus (90.5%), Capra 
hircus (90%) and Ovis aries (90%). These data further 
reaffirm the previous concept that GHs are highly 
conserved among various mammalian species (Nicoll et 
al., 1986; Chene et al., 1989). In earlier studies, prokar-
yotic system was used for over-expression of various 
rGH (Hodgson, 1993; Baneyx, 1999). Therefore, cGH 
cDNA was directionally sub cloned into pET23b+ 
expression vector under the control of strong T7 promoter 
and recombinant plasmid was then transformed into 




Expression of cGH 
 
In optimization strategy, various concentrations of IPTG 
were used with times of induction to obtain optimal 
conditions for the production of cGH and maximal amount 
of expressed protein was obtained at 3 h induction time 
with 100 µM IPTG concentrations. Expressed protein 
from induced culture was analyzed by 12% SDS-PAGE 
along with uninduced culture and the results are shown in 
Figure 1. Induced cells produced a distinct band 
corresponding to protein of approximately 21 kDa which 
constitutes a major part of total cellular proteins. It was 
observed that molecular weight of r-cGH is almost similar 
to that of cGH obtained from pituitary glands (Martinat et 
al., 1990).  
The r-cGH was expressed in 100 ml culture as IBs with 
small amounts in soluble fraction. It was observed earlier 
that proteins over expressed in prokaryotic system are 
unable to fold into proper conformation and hence tend to 
be sequestered in IBs (Clark, 1998). Similarly, production 
of growth hormone in the form of insoluble aggregates 




Solubilization of cGH inclusion bodies 
 
IBs from 100 ml of culture were washed to remove 
contaminants and the purified IBs were used for 
subsequent solubilization which is a critical step towards 
obtaining maximal amount of desired protein. Different 
denaturants and detergents such as guanidine HCl, urea, 
SDS, CTAB, cetyltrimethylammonium chloride (CTAC), 3-
[(3-cholamidopropyl) dimethylammonio]-1-propane-







Figure 1. 12% SDS-PAGE analysis of 
recombinant cGH expressed in BL21 (DE3) 
cells harboring cGH CDS-pET23b+ vector. 
Lane 1: lysate of uninduced cells (U), lane 2: 
lysate of induced cells (I), lane 3 and 4: 
supernatant and inclusion bodies after 
washing (S and IBs), lane 5: protein marker 




and Triton X-100 were used for the solubilization of 
animal GH and other recombinant proteins from inclusion 
bodies (Mitvaki and King, 1989; Sengupta et al., 2008). 
We used urea as a denaturant from 2 to 8 M 
concentration, SDS as an anionic detergent, CTAB as a 
cationic detergent, and Tween-20 and Triton X-100 as a 
nonionic detergents to determine the best possible 
solubilizing agent for r-cGH. These reagents have been 
used at their miceller concentrations (CMC) which has 
been widely reported for solublizing the IB protein 
(Arakawa et al., 1994; Burgess, 1996; Stockel et al., 
1997). The extent of solubilization was determined by 
running the solubilized samples on SDS-PAGE. Based 
on electrophoretic profile of solubilization through 
denaturant, that is, urea at different concentrations (2, 4, 
6 and 8 M) and pH (8 and 12.5), it was observed that 2 
and 4 M urea at pH 8 were not effective for solubilization, 
while 6 and 8 M urea showed little solubilization (Figure 
2A). However, maximum solubilization was observed 
when Tris buffer of pH 12.5 was used with the earlier 
mentioned concentration of urea (Figure 2B). Our results 
are in accordance with the previous study in which 
maximum solubilization of hGH IBs were achieved in 100 
mM Tris buffer at pH 12.5 containing 2 M urea (Patra et 
al., 2000). Among denaturants   used,   r-cGH  protein  
present  in  inclusion  




bodies was found to be highly soluble in SDS, partially 
soluble in CTAB and Tween-20 and insoluble in Triton X-
100 (Figure 3).  
In general, denaturants, that is, urea and guanidine HCl 
are used for solubilization of IBs. But the major draw 
backs to the use of these denaturants include low 
recovery, high cost and irreversible modifications to the 
protein structure (Marston, 1986; Schein, 1989). Solubili-
zation by high concentration of chaotropic reagents 
results in the loss of secondary structure, leading to the 
formation of protein aggregates due to the interaction 
among denatured protein molecules (Dill and Shortle, 
1991). It is expected that the overall yield of bioactive 
protein from the inclusion body would be higher if the 
existing secondary structure of the protein is protected 
during solubilization (Khan et al., 1998). It has been 
shown that the proteins solubilized in detergents retain 
secondary structure which may yield active protein and 
eliminate the refolding step (Crivelli et al., 1991). It was 
found in our studies that solubility achieved in 6 and 8 M 
urea in 100 mM Tris buffer at pH 12.5 was comparable to 
that of 8.5 mM SDS in 100 mM Tris buffer at pH 8. 
Therefore, SDS anionic detergent was preferred over 6 
and 8 M urea and used for further experiments.  
 
 
Purification and refolding of solubilized r-cGH  
 
Recombinant cGH was fractionated by gel filtration 
chromatography on Sephadex G-50 and further purified 
by using Sephadex G-100 column. The peak fractions 
were concentrated and loaded on SDS-PAGE for 
determining the efficiency of purification. Heterogeneous 
protein patterns along with a band corresponding to cGH 
were found after purification from Sephadex G-50 
column, whereas a single band of purified r-cGH was 
obtained from Sephadex G-100 column (Figure 4A). In 
another study, purification of equine GH was done by 
using Sephadex G-100 gel filtration chromatography 
twice (Conde et al., 1973).  
After purification, r-cGH protein was dialyzed in 20 mM 
Tris buffer pH 8 for renaturation with slight difference 
from the previously published method in which bGH was 
renatured by dialysis in 10 mM Tris HCl buffer pH 9.1 
(Choi et al., 1998). In another study, renaturation was 
achieved by decreasing concentration gradient dialysis 
(Wang et al., 2005). Recovery yield of purified r-cGH is 
summarized in Table 1. Western blot analysis confirmed 
the presence of r-cGH with expected size of 21 kDa in 
protein sample solubilized by SDS and purified by gel 
filtration. The results are presented in Figure 4B.  
 
 
Biological activity of r-cGH 
 
Biological activity of cGH was then checked by its growth 
promoting activity on Nb2 rat lymphoma cell  lines  in  the  
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Figure 2. 12% SDS-PAGE showing the solubility of r-cGH IBs in different concentrations of urea 
in 0.1 M Tris buffer, pH 8 (A) and 12.5 (B). Lane 1, Protein marker (Fermantas, Cat no. Sm0431), 
lane 2, commercially available bST Boostin (B); Lanes 3 and 4, 2 M urea; lanes 5 and 6, 4 M 
urea; lane 7 and 8, 6 M urea; lanes 9 and 10; 8 M urea (M, S and P are representing marker, 





                     











                               
 
 
    1    2    3    4    5    6   7   8    9   10 
M   B   S    P    S    P   S    P   S   P 
 
 
Figure 3. 12% SDS-PAGE showing the solubility of 
r-cGH IBs in different detergents. Lane 1, Protein 
marker (Fermantas, Cat no. Sm0431); Lane 2, 
commercially available bST (Boostin); Lanes 3 and 
4: 8.5 mM SDS; lanes 5 and 6, 6 mM CTAB; lanes 7 
and 8, 0.5 mM Triton X- 00; lanes 9 and 10, 0.06 
mM Tween-20 (M, S and P are representing marker, 
supernatant an pellet, respectively).  






Figure 4. 12% SDS-PAGE and Western blot analysis of purified r-cGH. (A) Lane 1, Protein marker 
(Fermantas, Cat no. Sm0431); Lane 2, commercially available bST (Boostin); Lane 3, peak I 
fractions of purification using Sephadex G-50 column (1.5 x 70); Lane 4, peak II fractions of 
purification using Sephadex G-100 column (1.5 x 70). (B) Lane 1, Prestained protein marker; Lane 
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Figure 5. Three independent experiments were run and this is representative experimental 





RPMI medium. Effect of additives (BSA, bST and r-cGH) 
on cell proliferation was observed by counting the cells 
after 72 h using haemocytometer. The result given in 
Figure 5 shows a comparable promoting activity of r-cGH 
on Nb2 lymphoma cells with commercially available bGH, 
whereas BSA did not show any growth promoting effect.  




Using one factor, ANOVA showed a significant 
difference (p ≤ 0.003) in the cell number of Nb2 
lymphoma cells between the control (BSA) and hormone 
treated cells (commercially available bGH and r-cGH) 
which is in line with reported data (Ouyang et al., 2003; 
Patra et al., 2000; Khan et al., 2009).  
It is therefore concluded that r-cGH protein expressed 
as IBs in E. coli can be obtained efficiently in a 
biologically active conformation by using 8.5 mM SDS in 
100 mM Tris-HCl buffer at pH 8.0. This study provide an 
efficient solubilization procedure for the recovery of 
bioactive r-cGH from the inclusion bodies which could be 
further applied for other therapeutic proteins expressed 
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